NEW YORK (GenomeWeb) – Veracyte announced today that it has signed a deal securing up to $45 million in financing from investment fund Visium Healthcare Partners.

Under the terms of the arrangement, Visium will provide Veracyte with a loan of $25 million, approximately $5 million of which will be used to retire the molecular diagnostics company's existing loan with Silicon Valley Bank. Veracyte may borrow an additional $15 million, at its option, through June 2017.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.